Literature DB >> 7603980

The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses.

T Ishikawa1, D Ganem.   

Abstract

In addition to their well-recognized hepatotropism, all hepatitis B viruses (HBVs) display marked species specificity, growing poorly or not at all in species other than those closely related to their natural hosts. We have examined the molecular basis for this narrow host range, using duck HBV (DHBV) and heron HBV (HHBV) as a model system. HHBV virions will not infect ducks in vivo and infect cultured duck hepatocytes extremely inefficiently in vitro. Mutant HHBV genomes lacking all viral envelope proteins (HHBV env-) can be complemented in trans with DHBV envelope proteins; the resulting pseudotyped virions can efficiently infect duck hepatocytes. Further complementation analysis reveals that of the two viral surface proteins (L and S), it is the L protein that determines host range. Pseudotyping of HHBV env- with DHBV/HHBV chimeric envelope proteins reveals that replacement of as few as 69 amino acids of the pre-S domain of the HHBV L protein by their DHBV counterparts is sufficient to permit infection of duck hepatocytes. These studies indicate that the species-specificity of hepadnaviral infection is determined at the level of virus entry and is governed by the pre-S domain of the viral L protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603980      PMCID: PMC41497          DOI: 10.1073/pnas.92.14.6259

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.

Authors:  S Staprans; D D Loeb; D Ganem
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide.

Authors:  J C Pugh; J W Summers
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

3.  Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.

Authors:  R C Cheung; D E Trujillo; W S Robinson; H B Greenberg; P L Marion
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

5.  Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA.

Authors:  R Hirsch; R Colgrove; D Ganem
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

6.  Analysis of the binding of a host cell surface glycoprotein to the preS protein of duck hepatitis B virus.

Authors:  T Ishikawa; K Kuroki; R Lenhoff; J Summers; D Ganem
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

7.  Efficient duck hepatitis B virus production by an avian liver tumor cell line.

Authors:  L D Condreay; C E Aldrich; L Coates; W S Mason; T T Wu
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions.

Authors:  C A Deminie; M Emerman
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo.

Authors:  J C Pugh; H Simmons
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  A cell surface protein that binds avian hepatitis B virus particles.

Authors:  K Kuroki; R Cheung; P L Marion; D Ganem
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  27 in total

1.  Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription.

Authors:  Jeffrey W Habig; Daniel D Loeb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 3.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 4.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Entry of duck hepatitis B virus into primary duck liver and kidney cells after discovery of a fusogenic region within the large surface protein.

Authors:  Claudia Maenz; Shau-Feng Chang; Alicja Iwanski; Michael Bruns
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

6.  A splice hepadnavirus RNA that is essential for virus replication.

Authors:  S Obert; B Zachmann-Brand; E Deindl; W Tucker; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

Review 7.  Quantification of HBsAg: basic virology for clinical practice.

Authors:  Jung Min Lee; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 8.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

9.  Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity.

Authors:  J Le Seyec; P Chouteau; I Cannie; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.